281 related articles for article (PubMed ID: 27229905)
21. Advances in immunotherapy delivery from implantable and injectable biomaterials.
Leach DG; Young S; Hartgerink JD
Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
[TBL] [Abstract][Full Text] [Related]
22. Current and future immunomodulation strategies to restore tolerance in autoimmune diseases.
Bluestone JA; Bour-Jordan H
Cold Spring Harb Perspect Biol; 2012 Nov; 4(11):. PubMed ID: 23125012
[TBL] [Abstract][Full Text] [Related]
23. The role of regulatory T Cells in autoimmune orchitis.
Jacobo P
Andrologia; 2018 Dec; 50(11):e13092. PubMed ID: 30569653
[TBL] [Abstract][Full Text] [Related]
24. Harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance.
Andorko JI; Hess KL; Jewell CM
AAPS J; 2015 Mar; 17(2):323-38. PubMed ID: 25533221
[TBL] [Abstract][Full Text] [Related]
25. Tailoring Materials for Modulation of Macrophage Fate.
Li J; Jiang X; Li H; Gelinsky M; Gu Z
Adv Mater; 2021 Mar; 33(12):e2004172. PubMed ID: 33565154
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic potential of regulatory T cells in autoimmune disorders.
Fessler J; Felber A; Duftner C; Dejaco C
BioDrugs; 2013 Aug; 27(4):281-91. PubMed ID: 23580095
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy in autoimmune neuromuscular disorders.
Gold R; Dalakas MC; Toyka KV
Lancet Neurol; 2003 Jan; 2(1):22-32. PubMed ID: 12849298
[TBL] [Abstract][Full Text] [Related]
28. Modern therapeutic strategies for autoimmune diseases.
Tyndall A
Curr Pharm Des; 2012; 18(29):4508-12. PubMed ID: 22612754
[TBL] [Abstract][Full Text] [Related]
29. Low-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunity.
Kosmaczewska A
Int J Mol Sci; 2014 Oct; 15(10):18574-92. PubMed ID: 25322151
[TBL] [Abstract][Full Text] [Related]
30. [Autoimmunity].
Müller C
Schweiz Med Wochenschr; 1997 Mar; 127(9):333-40. PubMed ID: 9132931
[TBL] [Abstract][Full Text] [Related]
31. Is JAK3 a new drug target for immunomodulation-based therapies?
Papageorgiou AC; Wikman LE
Trends Pharmacol Sci; 2004 Nov; 25(11):558-62. PubMed ID: 15491777
[TBL] [Abstract][Full Text] [Related]
32. Three distinct tolerogenic CD14
van Wigcheren GF; Roelofs D; Figdor CG; Flórez-Grau G
J Autoimmun; 2021 Jun; 120():102645. PubMed ID: 33901801
[TBL] [Abstract][Full Text] [Related]
33. T cell targeted immunotherapy for autoimmune disease.
Lee E; Sinha AA
Autoimmunity; 2005 Dec; 38(8):577-96. PubMed ID: 16390811
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in biomaterial-boosted adoptive cell therapy.
Xue Y; Che J; Ji X; Li Y; Xie J; Chen X
Chem Soc Rev; 2022 Mar; 51(5):1766-1794. PubMed ID: 35170589
[TBL] [Abstract][Full Text] [Related]
35. Materials engineering for immunomodulation.
Hubbell JA; Thomas SN; Swartz MA
Nature; 2009 Nov; 462(7272):449-60. PubMed ID: 19940915
[TBL] [Abstract][Full Text] [Related]
36. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
[TBL] [Abstract][Full Text] [Related]
37. The Potential Role of Schistosome-Associated Factors as Therapeutic Modulators of the Immune System.
Li J; Liu H; Jiang J; She X; Niu Y; Ming Y
Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32341115
[TBL] [Abstract][Full Text] [Related]
38. Dendritic cells: friend or foe in autoimmunity?
Santiago-Schwarz F
Rheum Dis Clin North Am; 2004 Feb; 30(1):115-34. PubMed ID: 15061571
[TBL] [Abstract][Full Text] [Related]
39. Biological therapies directed against cells in autoimmune disease.
Hasler P
Springer Semin Immunopathol; 2006 Jun; 27(4):443-56. PubMed ID: 16738955
[TBL] [Abstract][Full Text] [Related]
40. The Role of Natural-Based Biomaterials in Advanced Therapies for Autoimmune Diseases.
Ferreira H; Fangueiro JF; Neves NM
Adv Exp Med Biol; 2018; 1077():127-146. PubMed ID: 30357687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
